Ivana Djuretic
Overview
Explore the profile of Ivana Djuretic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
535
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sultan H, Takeuchi Y, Ward J, Sharma N, Liu T, Sukhov V, et al.
Nature
. 2024 Jul;
632(8023):182-191.
PMID: 39048822
CD4 T cells can either enhance or inhibit tumour immunity. Although regulatory T cells have long been known to impede antitumour responses, other CD4 T cells have recently been implicated...
2.
Andreata F, Moynihan K, Fumagalli V, Di Lucia P, Pappas D, Kawashima K, et al.
Sci Transl Med
. 2024 Jan;
16(729):eadi1572.
PMID: 38198572
CD8 T cells are key antiviral effectors against hepatitis B virus (HBV), yet their number and function can be compromised in chronic infections. Preclinical HBV models displaying CD8 T cell...
3.
Xu Y, Campos Carrascosa L, Yeung Y, Chu M, Yang W, Djuretic I, et al.
Cancer Immunol Res
. 2021 Aug;
9(10):1141-1157.
PMID: 34376502
The use of cytokines for immunotherapy shows clinical efficacy but is frequently accompanied by severe adverse events caused by excessive and systemic immune activation. Here, we set out to address...
4.
Sommer C, Cheng H, Nguyen D, Dettling D, Yeung Y, Sutton J, et al.
Mol Ther
. 2020 Jun;
28(10):2237-2251.
PMID: 32592688
Patients with relapsed or refractory acute myeloid leukemia (AML) have a dismal prognosis and limited treatment options. Chimeric antigen receptor (CAR) T cells have achieved unprecedented clinical responses in patients...
5.
Yeung Y, Krishnamoorthy V, Dettling D, Sommer C, Poulsen K, Ni I, et al.
Mol Ther
. 2020 Jan;
28(3):889-900.
PMID: 31981494
FLT3 (FMS-like tyrosine kinase 3), expressed on the surface of acute myeloid leukemia (AML) blasts, is a promising AML target, given its role in the development and progression of leukemia,...
6.
Duell J, Lammers P, Djuretic I, Chunyk A, Alekar S, Jacobs I, et al.
Clin Pharmacol Ther
. 2019 Feb;
106(4):781-791.
PMID: 30770546
Monoclonal antibody therapies are an important approach for the treatment of hematologic malignancies, but typically show low single-agent activity. Bispecific antibodies, however, redirect immune cells to the tumor for subsequent...
7.
He S, Gleason J, Fik-Rymarkiewicz E, Difiglia A, Bharathan M, Morschauser A, et al.
Stem Cells
. 2017 Feb;
35(6):1603-1613.
PMID: 28233380
Peripheral arterial disease (PAD) is a leading cause of limb loss and mortality worldwide with limited treatment options. Mesenchymal stromal cell (MSC) therapy has demonstrated positive effects on angiogenesis in...
8.
Guo X, Kaplunovsky A, Zaka R, Wang C, Rana H, Turner J, et al.
Wounds
. 2016 Nov;
29(1):28-38.
PMID: 27852013
Background: Decellularized, dehydrated human amniotic membrane (DDHAM) is an extracellular matrix devoid of cells, cell debris, and growth factors. This study examines the effect of cell attachment to the DDHAM...
9.
Hu H, Djuretic I, Sundrud M, Rao A
Trends Immunol
. 2007 Jul;
28(8):329-32.
PMID: 17618833
A general theme in gene regulation is that transcription factors never function alone. Recent studies have emphasized this concept for regulatory T cells, a unique lineage of CD4+ T cells...
10.
Ansel K, Djuretic I, Tanasa B, Rao A
Annu Rev Immunol
. 2006 Mar;
24:607-56.
PMID: 16551261
Helper T cells coordinate immune responses through the production of cytokines. Th2 cells express the closely linked Il4, Il13, and Il5 cytokine genes, whereas these same genes are silenced in...